Abilify represents antipsychotic remedy (neuroleptic). Abilify effectiveness comes out mainly due to aripiprazole presence. Aripiprazole's therapeutic effect in schizophrenia treatment is caused by partial agonist activity against dopamine D2 and 5HT1a and 5HT2 serotonin receptors.
Indications of Abilify:
• acute onset of schizophrenia (treatment and support therapy);
• treatment of bipolar disorder's acute manic episodes (first type);
• bipolar disorder (first type) supporting therapy after recently supported manic or mixed episodes.
Abilify is taken inside, meal regardless.
It is advised appointing of an initial dose amount of 10 or 15 mg for schizophrenia's treatment (take in abilify once a day). Hereafter the dose for effect's support is 15 mg/day.
Bipolar disorder's manic episodes are cured with an Initial Abilify's daily dose of 15 or 30 mg. Dose revising (if have need) is not recommended earlier than 24 hours.
Monitoring the patients affected of first type bipolar disorder and suffering manic or mixed episodes patients, having no symptoms during taking Abilify (if was taken a course dose of 15-30 mg (daily) and treatment started from 30 mg/day) wihin 6 weeks, indicates an auspicious effect of such supporting therapy.